The Enterprise Value as of June 2026 (TTM) for Brainstorm Cell Therapeutics Inc. (BCLI) is 9.75M

According to Brainstorm Cell Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.75M. This represents a change of 8.80% compared to the average of 8.96M of the last 4 quarters.

Brainstorm Cell Therapeutics Inc. (BCLI) Historical Enterprise Value (quarterly & annually)

How has BCLI Enterprise Value performed in the past?

The mean historical Enterprise Value of Brainstorm Cell Therapeutics Inc. over the last ten years is 65.44M. The current 9.75M Enterprise Value has changed 1.39% with respect to the historical average. Over the past ten years (40 quarters), BCLI's Enterprise Value was at its highest in in the September 2020 quarter at 503.86M. The Enterprise Value was at its lowest in in the December 2025 quarter at 6.24M.

Brainstorm Cell Therapeutics Inc. (BCLI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Brainstorm Cell Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Brainstorm Cell Therapeutics Inc. (BCLI) Average Enterprise Value

How has BCLI Enterprise Value performed in the past?

The current Enterprise Value of Brainstorm Cell Therapeutics Inc. (BCLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Brainstorm Cell Therapeutics Inc. (BCLI) Enterprise Value vs. Peers

How is BCLI’s Enterprise Value compared to its peers?

Brainstorm Cell Therapeutics Inc.’s Enterprise Value is less than NeuroSense Therapeutics Ltd. (18.14M), greater than Matinas BioPharma Holdings, Inc. (3.07M), greater than Adial Pharmaceuticals, Inc. (-1724361.00), greater than Cardio Diagnostics Holdings, Inc. (-2485596.00), greater than HCW Biologics Inc. (8.02M), greater than Impact BioMedical Inc. (7.29M), greater than Acurx Pharmaceuticals, Inc. (-6766398.00), greater than VYNE Therapeutics Inc. (-13823812.00), greater than Addex Therapeutics Ltd (4.62M), greater than BioCardia, Inc. (4.56M),

Build a custom stock screener for Brainstorm Cell Therapeutics Inc. (BCLI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brainstorm Cell Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brainstorm Cell Therapeutics Inc. (BCLI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brainstorm Cell Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.